Aebersold Sarah 4
4 · BIOLIFE SOLUTIONS INC · Filed Feb 26, 2026
Research Summary
AI-generated summary of this filing
BioLife (BLFS) CHRO Sarah Aebersold Receives Stock Award
What Happened Sarah Aebersold, Chief Human Resources Officer of BioLife Solutions (BLFS), received a market‑based restricted stock award that vested on Feb 24, 2026 for 23,548 shares (no cash price). To cover tax withholding on the vesting, 5,734 shares were withheld/disposed at an implied value of $22.65 per share, totaling $129,875. The award vested at ~156% of the originally granted number of shares based on BioLife’s total shareholder return vs. peers (see footnote).
Key Details
- Transaction dates: Award/vesting and withholding occurred on 2026-02-24; Form 4 filed 2026-02-26.
- Transactions reported: Code A (award/acquisition) — 23,548 shares acquired (vesting of restricted stock); Code F (tax withholding) — 5,734 shares withheld @ $22.65, value $129,875.
- Shares owned after transaction: Not specified in the filing.
- Footnotes: F1 — Vesting was market‑based and settled at ~156% of grant based on TSR vs. peers. F2 — 5,734 shares were withheld to satisfy tax withholding obligations.
- Timeliness: Form 4 filed two days after the transaction date (within normal reporting window).
Context This was a vested restricted stock award (market‑based performance award), not an open‑market purchase or voluntary sale. The withholding of shares to cover taxes is a routine administrative step and does not necessarily indicate a discretionary sale for cash; it simply satisfies the tax obligation arising from the vesting.
Insider Transaction Report
- Award
Common Stock
[F1]2026-02-24+23,548→ 99,313 total - Tax Payment
Common Stock
[F2]2026-02-24$22.65/sh−5,734$129,875→ 93,579 total
Footnotes (2)
- [F1]The restricted stock was granted pursuant to the BioLife Solutions 2023 Omnibus Performance Incentive Plan. In accordance with the terms of the grant, the restricted stock vested as to approximately 156% of the number of shares granted based on the registrant's total shareholder return during the period beginning on January 1, 2024 through December 31, 2025 as compared to the total shareholder return of certain of the registrant's peers (such peers have been determined by the registrant's compensation committee with assistance of an outside consultant immediately prior to the grant date).
- [F2]Represents shares withheld to cover tax withholding obligations in connection with the vesting of the market-based restricted stock award.